Dr. Éric A. Cohen, Team Leader and Principal Investigator for CanCURE, has just published a study in the scientific journal PLOS Pathogens. His research unit at the Institut de recherches cliniques de Montréal (IRCM), along with international collaborators, have shown how an HIV protein known as "Vpu" tricks the immune system by using its own regulatory process to evade the host’s first line of defence. Their discovery paves the way towards future therapeutic strategies for an HIV Cure. Moreover, their findings were announced through a press release issued today by the IRCM.
Read the press release by the IRCM >>
Read the article published in PLOS Pathogens >>
Media coverage of this scientific finding:
Journal de Montréal (French) >> / Journal de Québec (French) >>
TVA - Salut Bonjour (French)>>
TVA Nouvelles (French)>>
ICI Radio-Canada (French) >>
98,5 FM: Puisqu'il faut se lever (French) >>
Le Huffington Post - Québec (French) >>
McGill Reporter >>
Université de Montréal Nouvelles (French)>>
Canoe.ca Santé (French)>>
Actualités Scientifiques Sympatico (French)>>
La Presse+ (French)>>
Le Dr Éric Cohen (gauche) et la Dre Mariana Bego (droite).La Dre Bego est 1ère auteure de l'article et chercheuse associée au labo du Dr Cohen.